Send the following on WhatsApp
Continue to Chat慢性自發性蕁麻疹病人福音!Dupilumab 再申請新適應症 https://geneonline.news/chronic-spontaneous-urticaria-fda-dupilumab-sbla/
慢性自發性蕁麻疹病人福音!Dupilumab 再申請新適應症 https://geneonline.news/chronic-spontaneous-urticaria-fda-dupilumab-sbla/